The G72/G30 gene complex and cognitive abnormalities in schizophrenia. (Q48607760)

13 February 2018

title

The G72/G30 gene complex and cognitive abnormalities in schizophrenia. (English)

1 reference

13 February 2018

0 references

7

1 reference

13 February 2018

Daniel R. Weinberger

9

object named as

Daniel R Weinberger

1 reference

13 February 2018

Terry E Goldberg

1

1 reference

13 February 2018

Richard E Straub

2

1 reference

13 February 2018

Joseph H Callicott

3

1 reference

13 February 2018

Ahmad Hariri

4

1 reference

13 February 2018

Venkata S Mattay

5

1 reference

13 February 2018

Llewellyn Bigelow

6

1 reference

13 February 2018

Michael F Egan

8

1 reference

13 February 2018

language of work or name

English

0 references

publication date

22 March 2006

1 reference

13 February 2018

published in

Neuropsychopharmacology

1 reference

13 February 2018

volume

31

1 reference

13 February 2018

issue

9

1 reference

13 February 2018

page(s)

2022-2032

1 reference

13 February 2018

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301049

exact match

0 references

cites work

Neuropsychological assessment of monozygotic twins discordant for schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301049

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301049

Abnormal excitatory neurotransmitter metabolism in schizophrenic brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301049

Polymorphisms in the 13q33.2 gene G72/G30 are associated with childhood-onset schizophrenia and psychosis not otherwise specified

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301049

7 January 2021

Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301049

7 January 2021

Findings in an independent sample support an association between bipolar affective disorder and the G72/G30 locus on chromosome 13q33

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301049

7 January 2021

Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301049

7 January 2021

Genome-wide search for schizophrenia susceptibility loci: The NIMH genetics initiative and millennium consortium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301049

7 January 2021

Calpain 10 and genetics of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301049

7 January 2021

Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301049

7 January 2021

Impaired sensory processing as a basis for object-recognition deficits in schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301049

7 January 2021

Relative risk for cognitive impairments in siblings of patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301049

7 January 2021

The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301049

7 January 2021

Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301049

7 January 2021

Continuous performance test and schizophrenia: a test of stimulus-response compatibility, working memory, response readiness, or none of the above?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301049

7 January 2021

Visualizing genetic influences on human brain functions.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301049

7 January 2021

Genetic animal models: focus on schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301049

7 January 2021

Quantitative MRI of the temporal lobe, amygdala, and hippocampus in normal human development: ages 4-18 years.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301049

7 January 2021

The emerging role of glutamate in the pathophysiology and treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301049

7 January 2021

Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301049

7 January 2021

Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301049

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301049

1 reference

7 January 2021

Genes for schizophrenia? Recent findings and their pathophysiological implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301049

7 January 2021

Polymorphisms at the G72/G30 gene locus, on 13q33, are associated with bipolar disorder in two independent pedigree series

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301049

7 January 2021

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301049

7 January 2021

Effects of NMDA receptor antagonists: implications for the pathophysiology of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301049

7 January 2021

Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301049

7 January 2021

Sustained exposure to a glycine receptor partial agonist differentially alters NMDA receptor agonist and antagonist potencies in cultured spinal cord neurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301049

7 January 2021

Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301049

7 January 2021

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301049

7 January 2021

Dopaminergic modulation of cortical function in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301049

7 January 2021

Glutamate receptor expression in schizophrenic brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301049

7 January 2021

In search of general mechanisms for long-lasting plasticity: Aplysia and the hippocampus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301049

7 January 2021

Somatosensory input to auditory association cortex in the macaque monkey.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301049

7 January 2021

Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301049

7 January 2021

Glutamatergic mechanisms in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301049

7 January 2021

Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301049

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301049

1 reference

13 February 2018

PubMed ID

16554747

1 reference

13 February 2018